B. Donneaux
Papers
1
Total Citations
5
H-Index
1
About
Dr. B. Donneaux is a leading figure in the development of ultra-precise, minimally invasive cancer therapies, with a primary focus on stereotactic body radiotherapy (SBRT) for prostate cancer. Their most impactful work challenges the conventional treatment paradigm for low-risk disease. Donneaux’s landmark Phase-II trial, published in 2023, demonstrated that stereotactic focal radiotherapy—delivering a highly concentrated dose to only the tumor-bearing region—can serve as a safe and effective alternative to both radical whole-gland therapy and active surveillance. This approach preserves quality of life by dramatically reducing urinary, bowel, and sexual side effects while maintaining excellent cancer control. The study, which has already garnered 5 citations, is pioneering a new "middle ground" in prostate cancer management, offering patients a curative option without the morbidity of traditional treatments. Donneaux’s work is reshaping clinical guidelines, positioning focal SBRT as a potential new standard for select patients and opening the door for similar organ-sparing strategies in other malignancies.
Research Focus
Key Achievements
Top Papers
- 1